Ultime notizie per Milestone Scientific (AMEX:MLSS) Azioni

Milestone Scientific

Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.

Milestone Scientific Inc

Milestone Scientific GAAP EPS of -$0.02, revenue of $2.25M

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Milestone Scientific</strong> (NYSEMKT:<span><a href="https://investorplace.com/stock-quotes/mlss-stock-quote/"><strong>MLSS</strong></a></span>) just reported results for the first quarter of 2024.</p><ul><li>Milestone Scientific reported earnings per share of -2 cents.</li><li>The company reported revenue of $2.25 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/05/mlss-stock-earnings-milestone-scientific-for-q1-of-2024/">MLSS Stock Earnings: Milestone Scientific Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

MLSS Stock Earnings: Milestone Scientific Reported Results for Q1 2024

Milestone Scientific Inc. (MLSS) Q1 2024 Earnings Call Transcript

Maxim Group analyst Anthony Vendetti maintained a Buy rating on Milestone Scientific (MLSS – Research Report) yesterday and set a price target of $...

Milestone Scientific: A Buy Rating on Strong Financials and Market Expansion Potential

Milestone Scientific GAAP EPS of $0.00 beats by $0.01, revenue of $1.9M misses by $0.62M

Milestone Scientific Inc. (MLSS) Q2 2024 Earnings Call Transcript

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Milestone Scientific</strong> (NYSEMKT:<span><a href="https://investorplace.com/stock-quotes/mlss-stock-quote/"><strong>MLSS</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>The company did not report any EPS for the quarter.</li><li>The company reported revenue of $1.85 million.</li><li>This was 26.47% worse than the analyst estimate for revenue of $2.52 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/mlss-stock-earnings-milestone-scientific-for-q2-of-2024/">MLSS Stock Earnings: Milestone Scientific Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

MLSS Stock Earnings: Milestone Scientific Misses Revenue for Q2 2024

In a report released yesterday, Anthony Vendetti from Maxim Group reiterated a Buy rating on Milestone Scientific (MLSS – Research Report), with a ...

Milestone Scientific: A Strong Buy on Robust Financials and Market Expansion Potential

Milestone Scientific ( ($MLSS) ) has provided an update. TFF Pharma has released an investor presentation on its website, offering valuable insight...

Milestone Scientific Offers Insightful Online Investor Presentation

Milestone Scientific (MLSS) announced the commercial rollout of its CompuFlo Epidural System at Hudson Specialty Care, led by renowned physician Dr...

Milestone Scientific expands commercial rollout of CompuFlo Epidural System

MLSS

Earnings

Press Releases

Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024

General

Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil

Milestone Scientific Announces Favorable Medicare Pricing for its CompuFlo® Epidural System within First JMAC Region Covering Florida

Health Care

Milestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and Delaware

Milestone Scientific Secures Key Patent Approvals in the U.S. and Europe

Milestone Scientific Announces Strategic Partnership with Axial Biologics to Distribute CompuFlo® in New Jersey, Texas, and Florida

News

Milestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference Call

Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024

Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at iHeal Pain Center Following Medicare Price Assignment

Milestone Scientific Expands Commercial Rollout of the CompuFlo® Epidural System with Esteemed Pain Management Physician Dr. Elbaz at Hudson Specialty Care

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings

Apyx Medical

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics

Baird Medical Investment Holdings Ltd - Ordinary Share

Baird Medical Investment

HeartBeam

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

Co-Diagnostics

CytoSorbents

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

Daxor

electroCore

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

Comments

Milestone Scientific

Notizie

Ultime notizie per Milestone Scientific (AMEX:MLSS) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO